🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Study CP-MGC018-02 is a study of vobramitamab duocarmazine (MGC018) in comb...
Status
Completed
Location
University of California, Los Angeles
Start Date
2022-04-19
Trial ID
NCT05293496
Treatments Being Tested
To apply its findings as rationale needed for a subsequent registration tri...
Status
Withdrawn
Location
Multiple Locations
Start Date
2025-09-03
Trial ID
NCT07137390
Treatments Being Tested
To learn about the effects of the drugs regorafenib and lorigerlimab on cir...
Status
Recruiting
Location
MD Anderson Cancer Center
Start Date
2026-02-11
Trial ID
NCT07071961
Treatments Being Tested
This is a prospective single-center, single-arm, open-label, phase II study...
Status
Withdrawn
Location
Multiple Locations
Start Date
2025-10-27
Trial ID
NCT07223567
Treatments Being Tested
To learn if MGD019 can help to control cervical cancer in patients who have...
Status
Suspended
Location
M D Anderson Cancer Center
Start Date
2022-12-13
Trial ID
NCT05475171
Treatments Being Tested
The purpose of this study is to determine the objective response rate (ORR)...
Status
Not Yet Recruiting
Location
University of Miami
Start Date
2026-06-01
Trial ID
NCT07565155
Treatments Being Tested
The purpose of this study is to determine whether the amount of time before...
Status
Completed
Location
United Medical Group
Start Date
2023-09-28
Trial ID
NCT05848011
Treatments Being Tested
The purpose of this study is to evaluate the safety and tolerability, pharm...
Status
Completed
Location
University of Chicago Medical Center
Start Date
2018-12-12
Trial ID
NCT03761017
Treatments Being Tested
Study CP-MGD019-03 is an open-label study of lorigerlimab in participants w...
Status
Recruiting
Location
UCLA
Start Date
2025-05-01
Trial ID
NCT06730347
Treatments Being Tested